• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Mirum Pharma Announces Health Canada Authorization of Livmarli

    BUSINESSWIRE

    Mirum Pharma Acquires Bluejay to Boost Rare Disease Leadership

    BUSINESSWIRE

    Mirum Pharma Enters into Definitive Agreement to Acquire Bluejay

    PHARMIWEB

    Mirum Pharma Enrolls First Patient In BLOOM Ph2 Study

    BUSINESSWIRE

    Mirum Highlights LIVMARLI And Volixibat Data At Liver Meeting

    BUSINESSWIRE

    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq List

    BUSINESSWIRE

    FDA Approves First Treatment For Cerebrotendinous Xanthomatosis

    PR NEWSWIRE

    Rare Liver Disease Wins Mount as Mirum`s PFIC Trial Meets Endpoint - Updated

    BIOSPACE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.